• Türkçe
    • English
  • English 
    • Türkçe
    • English
  • Login
View Item 
  •   [email protected]
  • Araştırma Çıktıları | TR-Dizin | WoS | Scopus | PubMed
  • WoS İndeksli Yayınlar Koleksiyonu
  • View Item
  •   [email protected]
  • Araştırma Çıktıları | TR-Dizin | WoS | Scopus | PubMed
  • WoS İndeksli Yayınlar Koleksiyonu
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

18F-FDG-PET correlates of ımpulse control disorder in a diabetic patient

Access

info:eu-repo/semantics/closedAccess

Date

2016

Author

Yuluğ, Burak
Hanoğlu, Lütfü
Tavlı, Ahmet Mithat
Çakır, Tansel
Khanmammadov, Elmir
Olmusçelik, Oktay

Metadata

Show full item record

Citation

Yuluğ, B., Hanoğlu, L., Tavlı, A. M., Çakır, T., Khanmammadov, E. ve Olmusçelik, O. (2016). 18F-FDG-PET correlates of ımpulse control disorder in a diabetic patient. Endocrine Metabolic & Immune Disorders-Drug Targets, 16(3), 224-227. https://dx.doi.org/10.2174/1872214810666160930124951

Abstract

Background: Studies have already shown that hyperglycemia and insulin resistance are significantly associated with the impairment of cerebral glucose metabolism that may secondary lead to cognitive disturbances. In this study, we aimed to evaluate the neurometabolic correlates of diabetes in a patient with Intermittent explosive disorder (IED). Methods: We have investigated the cerebral glucose metabolism via 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in a diabetic patient with aggressive outbursts. Results: We have found significantly reduced glucose uptake in left temporoparietal region, pontin area, and left nucleus lentiformis. Discussion: Our present results indicate decreased cerebral glucose metabolism in specific cerebral cortical and subcortical areas. The main limitation of this report is that, this is a single case study and that these findings need to be replicated in well-conducted randomized controlled studies by using additional neuroquantitative methods.

WoS Q Kategorisi

Q3

xmlui.dri2xhtml.METS-1.0.item-scopusquality

Q3

Source

Endocrine Metabolic & Immune Disorders-Drug Targets

Volume

16

Issue

3

URI

https://dx.doi.org/10.2174/1872214810666160930124951
https://hdl.handle.net/20.500.12511/2331

Collections

  • Makale Koleksiyonu [3194]
  • PubMed İndeksli Yayınlar Koleksiyonu [3494]
  • Scopus İndeksli Yayınlar Koleksiyonu [5333]
  • WoS İndeksli Yayınlar Koleksiyonu [5545]



DSpace software copyright © 2002-2015  DuraSpace
Contact Us | Send Feedback
Theme by 
@mire NV
 

 




| Guide | Contact |

[email protected]

by OpenAIRE
Advanced Search

sherpa/romeo

Browse

All of DSpaceCommunities & CollectionsBy Issue DateAuthorsInstitution AuthorORCIDTitlesSubjectsTypeLanguageDepartmentCategoryWoS Q ValueScopus Q ValuePublisherAccess TypeThis CollectionBy Issue DateAuthorsInstitution AuthorORCIDTitlesSubjectsTypeLanguageDepartmentCategoryWoS Q ValueScopus Q ValuePublisherAccess Type

My Account

LoginRegister

Statistics

View Google Analytics Statistics

DSpace software copyright © 2002-2015  DuraSpace
Contact Us | Send Feedback
Theme by 
@mire NV
 

 


|| Guide || Library || İstanbul Medipol University || OAI-PMH ||

Kütüphane ve Dokümantasyon Daire Başkanlığı, İstabul, Turkey
If you find any errors in content, please contact: [email protected]

Creative Commons License
[email protected] by İstanbul Medipol University Institutional Repository is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 Unported License..

[email protected]:


DSpace 6.2

tarafından İdeal DSpace hizmetleri çerçevesinde özelleştirilerek kurulmuştur.